Too many of our friends and family members are dying from colorectal cancer, the second deadliest cancer in the U.S.
Treatment for CRC that has spread to other organs has improved incrementally over the years, but the five-year survival rate remains low — just 13%. More than 50,000 patients in the U.S. lose their lives to this disease every year.
Current CRC research funding amounts to $1,599 per diagnosis annually — fewer dollars than other less deadly cancers. At the same time, data suggests CRC will become the deadliest cancer among people under age 50 by 2030.
Progress can be better than incremental, which is why the Alliance established Project Cure CRC, a strategic endeavour to fund scientific breakthroughs. Project Cure CRC is for patients, known and loved, lost and remembered. People like ...
Driven by love for his family, Jason persevered for years, desperate for a cure. Often brought to tears by the thought of dying, he still found the generosity and courage to advance CRC awareness. Jason died on November 21, 2023, at age 51.
After five years of aggressive therapy, Jenna has reached the ultimate impasse — an empty list of treatment options. Cam, her son, asks his mom to never leave. Jenna says she never will, wishing that it’s true. She waits for progress.
In what she called her “last room,” Amy endeavoured to show her teenage children how to be resilient, grateful, and unafraid. Despite sluggish steps, mixed-up thoughts, and omnipresent pain, Amy remained resolute in her optimism. She died on November 27, 2024.
Designed to disrupt, transform, and accelerate research, Project Cure CRC seeks to inspire collaboration and accelerate science, bringing new treatments from bench to bedside faster.